These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25497177)

  • 1. Biodistribution of nanostructured lipid carriers: a tomographic study.
    Esposito E; Boschi A; Ravani L; Cortesi R; Drechsler M; Mariani P; Moscatelli S; Contado C; Di Domenico G; Nastruzzi C; Giganti M; Uccelli L
    Eur J Pharm Biopharm; 2015 Jan; 89():145-56. PubMed ID: 25497177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoid antagonist in nanostructured lipid carriers (NLCs): design, characterization and in vivo study.
    Esposito E; Ravani L; Drechsler M; Mariani P; Contado C; Ruokolainen J; Ratano P; Campolongo P; Trezza V; Nastruzzi C; Cortesi R
    Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():328-36. PubMed ID: 25579930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization and radiolabeling of folic acid modified nanostructured lipid carriers as a contrast agent and drug delivery system.
    Ucar E; Teksoz S; Ichedef C; Kilcar AY; Medine EI; Ari K; Parlak Y; Sayit Bilgin BE; Unak P
    Appl Radiat Isot; 2017 Jan; 119():72-79. PubMed ID: 27866122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution.
    Beloqui A; Solinís MÁ; Delgado A; Evora C; Isla A; Rodríguez-Gascón A
    J Microencapsul; 2014; 31(1):1-8. PubMed ID: 23631381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticulate lipid dispersions for bromocriptine delivery: characterization and in vivo study.
    Esposito E; Mariani P; Ravani L; Contado C; Volta M; Bido S; Drechsler M; Mazzoni S; Menegatti E; Morari M; Cortesi R
    Eur J Pharm Biopharm; 2012 Feb; 80(2):306-14. PubMed ID: 22061262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies.
    Jia L; Zhang D; Li Z; Duan C; Wang Y; Feng F; Wang F; Liu Y; Zhang Q
    Colloids Surf B Biointerfaces; 2010 Oct; 80(2):213-8. PubMed ID: 20621458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural investigations on nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers by cryo-field emission scanning electron microscopy and Raman spectroscopy.
    Saupe A; Gordon KC; Rades T
    Int J Pharm; 2006 May; 314(1):56-62. PubMed ID: 16574354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-dopa co-drugs in nanostructured lipid carriers: A comparative study.
    Cortesi R; Esposito E; Drechsler M; Pavoni G; Cacciatore I; Sguizzato M; Di Stefano A
    Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():168-176. PubMed ID: 28024573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
    Tiwari R; Pathak K
    Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin-loaded nanostructured lipid carriers (NLCs) for nasal administration: design, characterization, and in vivo study.
    Madane RG; Mahajan HS
    Drug Deliv; 2016 May; 23(4):1326-34. PubMed ID: 25367836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A coupled bimodal SPECT-CT imaging and brain kinetics studies of zolmitriptan-encapsulated nanostructured polymeric carriers.
    Mandlik SK; Ranpise NS; Mohanty BS; Chaudhari PR
    Drug Deliv Transl Res; 2018 Jun; 8(3):797-805. PubMed ID: 29380155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured lipid carriers as nitroxide depot system measured by electron paramagnetic resonance spectroscopy.
    Haag SF; Chen M; Peters D; Keck CM; Taskoparan B; Fahr A; Teutloff C; Bittl R; Lademann J; Schäfer-Korting M; Meinke MC
    Int J Pharm; 2011 Dec; 421(2):364-9. PubMed ID: 22001533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability.
    Zhuang CY; Li N; Wang M; Zhang XN; Pan WS; Peng JJ; Pan YS; Tang X
    Int J Pharm; 2010 Jul; 394(1-2):179-85. PubMed ID: 20471464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanostructured lipid carrier based topical gel of Ganoderma Triterpenoids for frostbite treatment.
    Shen CY; Dai L; Shen BD; Zhou X; Bai JX; Xu H; Lv QY; Han J; Yuan HL
    Chin J Nat Med; 2015 Jun; 13(6):454-60. PubMed ID: 26073342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
    Fan X; Chen J; Shen Q
    Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine.
    Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D
    Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route.
    Gabal YM; Kamel AO; Sammour OA; Elshafeey AH
    Int J Pharm; 2014 Oct; 473(1-2):442-57. PubMed ID: 25062866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies.
    Vairo C; Collantes M; Quincoces G; Villullas S; Peñuelas I; Pastor M; Gil AG; Gainza E; Hernandez RM; Igartua M; Gainza G
    Int J Pharm; 2019 Oct; 569():118484. PubMed ID: 31260785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution of Nanostructured Lipid Carriers (NLCs) after intravenous administration to rats: influence of technological factors.
    Beloqui A; Solinís MA; Delgado A; Evora C; del Pozo-Rodríguez A; Rodríguez-Gascón A
    Eur J Pharm Biopharm; 2013 Jun; 84(2):309-14. PubMed ID: 23461861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.